No Data
No Data
MAIA Biotechnology Announces Share Purchases by Directors Cristian Luput and Ramiro Guerrero
Company recognizes significant support by board members in recent private placement MAIA Biotechnology, Inc., (NYSE:MAIA) ("MAIA", the "Company"), a clinical-stage biopharmaceutical company developing targeted
MAIA Biotechnology Announces Share Purchase by Director Adelina Louie in Private Placement
Five independent members of MAIA's Board of Directors purchased shares in the offering MAIA Biotechnology, Inc., (NYSE:MAIA) ("MAIA", the "Company"), a clinical-stage biopharmaceutical company developing targeted
MAIA Biotechnology Announces $1.33 Million Private Placement
MAIA Biotechnology, Inc., (NYSE:MAIA) ("MAIA", the "Company"), a clinical-stage biopharmaceutical company developing targeted immunotherapies for cancer, today announced that it has entered into definitive agreements
MAIA Biotechnology Increased Maximum Aggregate Offering Price Of Shares Of Common Stock, Issuable Under At Market Offering Agreement
MAIA Biotechnology Increased Maximum Aggregate Offering Price Of Shares Of Common Stock, Issuable Under At Market Offering Agreement
CGC, CYTO and IDN Are Among Mid-day Movers
MAIA Biotechnology at Risk of NYSE Delisting Over Equity Shortfalls
No Data